FR2450827A1 - Composes du guanidinothiazole utiles comme inhibiteurs des secretions d'acide gastrique, leurs procedes de preparation et les compositions medicales contenant de tels composes - Google Patents

Composes du guanidinothiazole utiles comme inhibiteurs des secretions d'acide gastrique, leurs procedes de preparation et les compositions medicales contenant de tels composes

Info

Publication number
FR2450827A1
FR2450827A1 FR8004690A FR8004690A FR2450827A1 FR 2450827 A1 FR2450827 A1 FR 2450827A1 FR 8004690 A FR8004690 A FR 8004690A FR 8004690 A FR8004690 A FR 8004690A FR 2450827 A1 FR2450827 A1 FR 2450827A1
Authority
FR
France
Prior art keywords
alprene
compounds
inhibitors
guanidinothiazole
gastric acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR8004690A
Other languages
English (en)
French (fr)
Other versions
FR2450827B1 (en, 2012
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yamanouchi Pharmaceutical Co Ltd
Original Assignee
Yamanouchi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2574579A external-priority patent/JPS55118476A/ja
Priority claimed from JP7950879A external-priority patent/JPS565469A/ja
Application filed by Yamanouchi Pharmaceutical Co Ltd filed Critical Yamanouchi Pharmaceutical Co Ltd
Publication of FR2450827A1 publication Critical patent/FR2450827A1/fr
Application granted granted Critical
Publication of FR2450827B1 publication Critical patent/FR2450827B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/48—Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
FR8004690A 1979-03-06 1980-03-03 Composes du guanidinothiazole utiles comme inhibiteurs des secretions d'acide gastrique, leurs procedes de preparation et les compositions medicales contenant de tels composes Granted FR2450827A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2574579A JPS55118476A (en) 1979-03-06 1979-03-06 Novel amidine derivative and its preparation
JP7950879A JPS565469A (en) 1979-06-23 1979-06-23 Novel amidine derivative and its preparation
KR1019800000932A KR830002478B1 (ko) 1979-03-06 1980-03-06 구아니디노 티아졸 화합물의 제조방법

Publications (2)

Publication Number Publication Date
FR2450827A1 true FR2450827A1 (fr) 1980-10-03
FR2450827B1 FR2450827B1 (en, 2012) 1983-03-25

Family

ID=27285138

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8004690A Granted FR2450827A1 (fr) 1979-03-06 1980-03-03 Composes du guanidinothiazole utiles comme inhibiteurs des secretions d'acide gastrique, leurs procedes de preparation et les compositions medicales contenant de tels composes

Country Status (11)

Country Link
US (1) US4362736A (en, 2012)
CA (1) CA1145345A (en, 2012)
CH (1) CH644114A5 (en, 2012)
DE (1) DE3008056A1 (en, 2012)
ES (1) ES489222A0 (en, 2012)
FR (1) FR2450827A1 (en, 2012)
GB (1) GB2052478B (en, 2012)
IT (1) IT1165509B (en, 2012)
NL (1) NL8001361A (en, 2012)
PH (1) PH16099A (en, 2012)
SE (1) SE447253B (en, 2012)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0060094A3 (en) * 1981-03-09 1982-11-17 Imperial Chemical Industries Plc Guanidine derivatives
EP0060093A3 (en) * 1981-03-09 1982-11-17 Imperial Chemical Industries Plc Amide derivatives
EP0067508A1 (en) * 1981-05-18 1982-12-22 Imperial Chemical Industries Plc Amidine derivatives
FR2537134A1 (fr) * 1982-12-03 1984-06-08 Kotobuki Seiyaku Co Ltd Derives de thiazole et leur procede de synthese
EP0150099A1 (en) * 1984-01-24 1985-07-31 Imperial Chemical Industries Plc Guanidine derivatives
EP0061318B1 (en) * 1981-03-24 1985-10-09 Imperial Chemical Industries Plc Guanidinoheterocyclic derivatives as histamine h-2 antagonists
FR2569692A1 (fr) * 1984-08-30 1986-03-07 Yamanouchi Pharma Co Ltd Procede de preparation de derives de guanidinothiazole
EP0284536A1 (en) * 1987-02-20 1988-09-28 Centro Marga Para La Investigacion S.A. A process for the preparation of 3-(2-guanidinothiazol-4-yl-methylthio)propionitrile

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ196923A (en) * 1980-04-29 1983-12-16 Shionogi & Co 2-guanidino-4-(-acylaminoalkyl(thio)methyl)thiazoles and analogs
IN158869B (en, 2012) * 1981-03-18 1987-02-07 Ici Plc
JPS5872571A (ja) * 1981-10-27 1983-04-30 Shionogi & Co Ltd ２−グアニジノ−４−〔２−（ホルムアミド）エチルチオメチル〕チアゾ−ルの製法
US4808589A (en) * 1982-02-20 1989-02-28 Smith Kline & French Laboratories Limited Pyrimidone derivatives
EP0103390A3 (en) * 1982-08-13 1986-02-26 Imperial Chemical Industries Plc Guanidine-containing esters as histamine h2 receptor blockers
DE3238867A1 (de) * 1982-10-20 1984-04-26 Ludwig Heumann & Co GmbH, 8500 Nürnberg Heterocyclische verbindungen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
JPS59227870A (ja) * 1983-06-07 1984-12-21 Yamanouchi Pharmaceut Co Ltd 新規２−グアニジノチアゾリン誘導体ならびにその製造法
US4663347A (en) 1983-10-31 1987-05-05 Merck Frosst Canada, Inc. Benzofuran 2-carboxylic acid esters useful as inhibitors of leukotriene biosynthesis
CA1309557C (en) 1985-06-18 1992-10-27 Robert N. Young Leukotriene antagonists
DE3786030T2 (de) 1986-03-27 1993-12-02 Merck Frosst Canada Inc Tetrahydrocarbazole Ester.
US5428033A (en) 1990-10-12 1995-06-27 Merck Frosst Canada, Inc. Saturated hydroxyalkylquinoline acids as leukotriene antagonists
US5410054A (en) * 1993-07-20 1995-04-25 Merck Frosst Canada, Inc. Heteroaryl quinolines as inhibitors of leukotriene biosynthesis
TW200517114A (en) 2003-10-15 2005-06-01 Combinatorx Inc Methods and reagents for the treatment of immunoinflammatory disorders
ZA200804550B (en) 2005-11-09 2009-08-26 Combinatorx Inc Methods, compositions, and kits for the treatment of medical conditions
JP6378179B2 (ja) 2013-07-03 2018-08-22 株式会社新日本科学 新規化合物，有機カチオントランスポーター３の検出剤及び活性阻害剤
EP2929884A1 (en) 2014-04-11 2015-10-14 Sanovel Ilac Sanayi ve Ticaret A.S. Pharmaceutical combinations of dabigatran and h2-receptor antagonists
EP2942058A1 (en) 2014-05-09 2015-11-11 Sanovel Ilac Sanayi ve Ticaret A.S. Pharmaceutical combinations of rivaroxaban and H2-receptor antagonists
WO2021183259A1 (en) * 2020-03-12 2021-09-16 Nanopharmaceutics, Inc. Famotidine and famotidine analogs for corona virus treatment
US20230349922A1 (en) 2020-08-11 2023-11-02 Université De Strasbourg H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2387970A1 (fr) * 1977-04-20 1978-11-17 Ici Ltd Derives de la guanidine et medicament en contenant
US4165378A (en) * 1977-04-20 1979-08-21 Ici Americas Inc. Guanidine derivatives of imidazoles and thiazoles

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2817078C2 (de) * 1977-04-20 1995-06-14 Zeneca Ltd Guanidinderivate
JPS6056143B2 (ja) * 1979-08-02 1985-12-09 山之内製薬株式会社 アミジン誘導体ならびにその製造法

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2387970A1 (fr) * 1977-04-20 1978-11-17 Ici Ltd Derives de la guanidine et medicament en contenant
US4165378A (en) * 1977-04-20 1979-08-21 Ici Americas Inc. Guanidine derivatives of imidazoles and thiazoles

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0060094A3 (en) * 1981-03-09 1982-11-17 Imperial Chemical Industries Plc Guanidine derivatives
EP0060093A3 (en) * 1981-03-09 1982-11-17 Imperial Chemical Industries Plc Amide derivatives
EP0061318B1 (en) * 1981-03-24 1985-10-09 Imperial Chemical Industries Plc Guanidinoheterocyclic derivatives as histamine h-2 antagonists
EP0067508A1 (en) * 1981-05-18 1982-12-22 Imperial Chemical Industries Plc Amidine derivatives
FR2537134A1 (fr) * 1982-12-03 1984-06-08 Kotobuki Seiyaku Co Ltd Derives de thiazole et leur procede de synthese
EP0150099A1 (en) * 1984-01-24 1985-07-31 Imperial Chemical Industries Plc Guanidine derivatives
FR2569692A1 (fr) * 1984-08-30 1986-03-07 Yamanouchi Pharma Co Ltd Procede de preparation de derives de guanidinothiazole
EP0284536A1 (en) * 1987-02-20 1988-09-28 Centro Marga Para La Investigacion S.A. A process for the preparation of 3-(2-guanidinothiazol-4-yl-methylthio)propionitrile

Also Published As

Publication number Publication date
PH16099A (en) 1983-06-24
FR2450827B1 (en, 2012) 1983-03-25
IT8067346A0 (it) 1980-03-05
IT1165509B (it) 1987-04-22
ES8103070A1 (es) 1981-02-16
NL8001361A (nl) 1980-09-09
GB2052478B (en) 1983-04-07
DE3008056C2 (en, 2012) 1988-07-21
CH644114A5 (de) 1984-07-13
GB2052478A (en) 1981-01-28
CA1145345A (en) 1983-04-26
DE3008056A1 (de) 1980-09-18
US4362736A (en) 1982-12-07
ES489222A0 (es) 1981-02-16
SE8001691L (sv) 1980-09-07
SE447253B (sv) 1986-11-03

Similar Documents

Publication Publication Date Title
FR2450827A1 (fr) Composes du guanidinothiazole utiles comme inhibiteurs des secretions d'acide gastrique, leurs procedes de preparation et les compositions medicales contenant de tels composes
ES8107185A1 (es) Procedimiento para preparar piperidinas y pirrolidinas sus- tituidas
BE900345A (fr) Composition pharmaceutique ophtalmiques a base d'un derive d'acide phenylacetique.
ES483289A1 (es) Un procedimiento para la preparacion de 1,2,3,5, tetrahidro-himidazotienopirimidin-2-onas.
FR2413389A1 (fr) Composes a tete de pont azotee ayant une action anti-allergique et procede pour leur preparation
IE782115L (en) Imidazole derivatives
BE905110A (fr) Poly-4-aminopyrrole-2-carboxamides et derives, procede pour leur preparation et leurs utilisations therapeutiques.
FR2408584A1 (fr) Composes guanidinobenzoiques et possedant une activite antifibrinolysine et antitrypsine et leur procede de preparation
CA2079548A1 (en) Carbamate derivatives of 4-amino-3- isoxazolidinones, 3-amino-1- hydroxypyrrolidin-2-ones and 1-amino-1- cyclopropanecarboxylic acid analogs, a process for their preparation and their use as medicaments
GB1436978A (en) Choline derivatives and pharmaceutical compositions containing the same
FR2637286A1 (fr) Nouveaux derives benzoxazolinoniques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
FR2456765A1 (fr) Composes iminoisoindoliniques, leur procede de preparation et leur application comme pigments
FR2407941A1 (fr) Nouveaux derives de cholesterol
FR2449691A1 (fr) Procede de preparation de beta-lactames a proprietes antibiotiques
GB1480836A (en) Physiologically active xanthine derivatives and compositions containing them
ES8705362A1 (es) Un procedimiento para la preparacion de nuevas aminas terciarias
FR2438048A1 (fr) Nouveaux derives de 1,3-oxazino (5,6-c) rifamycine doues d'une activite antibiotique
FR2411173A1 (fr) Anthranilates de n-hydroxyalkyl-carboxamides et leur application comme reticulants
FR2413358A1 (fr) Nouveaux derives de 2-aminomethylphenol, utiles notamment comme agents anti-inflammatoires, et leur procede de preparation
FR2592648A1 (fr) Composes polyfluoroalkylthio-methyliques, leurs procedes de preparation et leurs applications comme agents tensio-actifs ou precurseurs de ces derniers.
FR2413370A1 (fr) Trans-4a-aryl-octahydro-1h-2-pyrindines et leur utilisation therapeutique
ATE5145T1 (de) O-creatinolphosphatderivat mit therapeutischer wirkung, verfahren zu dessen herstellung und dessen pharmazeutische zusammensetzungen.
FR2447375A1 (fr) Analogues de la prostaglandine e1 et compositions pharmaceutiques les contenant
TNSN87043A1 (fr) Derives dissymetriques de l'acide 1,4-dihydropyridine-3,5- dicarboxylique, procedes de preparation et utilisation en therapeutique
FR2390954A1 (fr) Nouvelles guanylhydrazones, leurs procedes de preparation et medicaments les contenant

Legal Events

Date Code Title Description
ST Notification of lapse